Mesenchymal neoplasms arising in the digestive tract are rare compared to adenomas and carcinomas [1]. They include several entities with histomorphological similarity and immunohistochemistry helps to confirm the diagnosis [2]. Our goals are to study the epidemiological aspect of mesenchymal tumors, and to compare the histological diagnoses before and after the use of immunochemistry. This is a retrospective, descriptive, single-center study performed on all cases of mesenchymal tumors in gastrointestinal tract, diagnosed at the laboratory of Pathological Anatomy Unit of Joseph Ravoahangy Andrianavalona University Hospital from January 1, 2007 to December 31, 2018. We included 29 cases. The mean age was 43.28 years. The sex ratio was 1.07. After immunohistochemical examination, 24.14% of tumors changed diagnosis to GISTs which are the most common mesenchymal tumor involving the gastrointestinal tract. In all cases of mesenchymal tumors of the gastrointestinal tract GIST should first be ruled out before making other diagnoses. Histologic and immunophenotypic features are thereby essential. According to the literature review, if c-Kit and DOG-1 are negative, molecular biology must be used.
References
[1]
Miettinen, M., Sarlomo-Rikala, M. and Lasota, J. (1998) Gastrointestinal Stromal Tumors. Annales Chirurgiae et Gynaecologiae, 87, 278-281.
[2]
Lamps, L.W., Bellizzi, A.M., Frankel, W.L., Owens, S.R., and Yantiss, R.K. (2015) Neoplastic Gastrointestinal Pathology: An Illustrated Guide. Springer Publishing Company, New York.
[3]
Rubin, B.P. and Hornick, J.L. (2019) Mesenchymal Tumors of the Gastrointestinal tract. Practical Soft Tissue Pathology: A Diagnostic Approach. Elsevier, Amsterdam, 459-498. https://doi.org/10.1016/B978-0-323-49714-5.00016-8
[4]
Sbaraglia, M., Businello, G., Bellan, E., Fassan, M. and Dei Tos, A.P. (2021) Mesenchymal Tumours of the Gastrointestinal Tract. Pathologica, 113, 230. https://doi.org/10.32074/1591-951X-309
[5]
Nilsson, B., Bümming, P., Meis-Kindblom, J.M., et al. (2005) Gastrointestinal Stromal Tumors: The Incidence, Prevalence, Clinical Course, and Prognostication in the Preimatinib Mesylate Era—A Population-Based Study in Western Sweden. Cancer, 103, 821-829. https://doi.org/10.1002/cncr.20862
[6]
Kamoun, S., M’Sakni, I., Mansouri, N., et al. (2015) Reclassification of Gastrointestinal Mesenchymal Tumors. La Tunisie Medicale, 93, 746-749.
[7]
Trabelsi, A., Mestiri, S., Stita, W., Mokni, A., et al. (2007) Les tumeurs mésenchymateuses du tube digestif, apport de l’immunohistochimie. Annales de Biologie Clinique, 65, 365-368.
[8]
Fletcher, C.D., Berman, J.J., Corless, C., et al. (2002) Diagnosis of Gastrointestinal Stromal Tumors: A Consensus Approach. Human Pathology, 33, 459-465. https://doi.org/10.1053/hupa.2002.123545
[9]
Kindblom, L.G., Remotti, H.E., Aldenborg, F. and Meis-Kindblom, J.M. (1998) Gastrointestinal Pacemaker Cell Tumor (GIPACT): Gastrointestinal Stromal Tumors Show Phenotypic Characteristics of the Interstitial Cells of Cajal. The American Journal of Pathology, 152, 1259-1269.
[10]
Coindre, J.M., Emile, J.F., Monges, G., Ranchère-Vince, D. and Scoazec, J.Y. (2005) Tumeurs stromales gastro-intestinales : définition, caractéristiques histologiques, immunohistochimiques et génétiques, stratégie diagnostique. Annales de Pathologie, 25, 358-385. https://doi.org/10.1016/S0242-6498(05)80145-2
[11]
Corless, C.L., Fletcher, J.A. and Heinrich, M.C. (2004) Biology of Gastrointestinal Stromal Tumors. Journal of Clinical Oncology, 22, 3813-3825. https://doi.org/10.1200/JCO.2004.05.140
[12]
Mazur, M.T. and Clark, H.B. (1983) Gastric Stromal Tumors. Reappraisal of histogenesis. The American Journal of Surgical Pathology, 7, 507-519. https://doi.org/10.1097/00000478-198309000-00001
[13]
Liegl-Atzwanger, B., Fletcher, J.A. and Fletcher, C.D.M. (2010) Gastrointestinal Stromal Tumors. Virchows Archiv, 456, 111-127. https://doi.org/10.1007/s00428-010-0891-y
[14]
Lopes, L.F., West, RB, Bacchi, L.M., Van de Rijn, M. and Bacchi, C.E. (2010) DOG1 for the Diagnosis of Gastrointestinal Stromal Tumor (GIST): Comparison between 2 Different Antibodies. Applied Immunohistochemistry & Molecular Morphology, 18, 333-337. https://doi.org/10.1097/PAI.0b013e3181d27ec8
[15]
Miettinen, M., Wang, Z.F. and Lasota, J. (2009) DOG1 Antibody in the Differential Diagnosis of Gastrointestinal Stromal Tumors a Study of 1840 Cases. The American Journal of Surgical Pathology, 33, 1401-1408. https://doi.org/10.1097/PAS.0b013e3181a90e1a
[16]
Liegl, B., Hornick, J.L., Corless, C.L. and Fletcher, C.D.M. (2009) Monoclonal Antibody DOG1.1 Shows Higher Sensitivity Than KIT in the Diagnosis of Gastrointestinal Stromal Tumors, Including Unusual Subtypes. The American Journal of Surgical Pathology, 33, 437-446. https://doi.org/10.1097/PAS.0b013e318186b158
